Skip to content
value.today

Johnson & Johnson: valuation

What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.

Cash-flow value and what the price assumes

$M

Average of FY2024–FY2025 (cash from operations less capital spending), from the statements below.

%

No three-year revenue growth on file: 5% to start with.

%

US Treasury 10-year yield on Nov 20, 2026: 4.92% (US Treasury).

%

Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.

%

Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.

$M

Debt or cash not on file: 0 to start with.

What today's price assumes

A market value of $652.5 B means free cash flow growing 14.3% a year for 10 years, then 2.5% for ever, at a 9.92% discount rate.

Cash-flow value of the shares
$327.8 B
-50% against the market value
Value of the whole business
$327.8 B
before net debt
Value from after year 10
53%
of the business value

Against the market value, for other rates

Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.

Sensitivity of the cash-flow value to the discount rate and the growth rate
Discount rate ↓ / growth →0%2.5%5%7.5%10%
7.92%-53%-43%-30%-15%+3%
8.92%-60%-52%-42%-29%-15%
9.92%-65%-58%-50%-40%-27%
10.92%-69%-63%-56%-47%-37%
11.92%-72%-67%-61%-54%-45%

On one scale

Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.

Cash-flow value$0 M$176.2 B$352.3 B$528.5 B$704.7 BMarket value $652.5 B

Your own DCF model

A full discounted-cash-flow model of Johnson & Johnson, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.

Open the DCF model

Against its own history

Johnson & Johnson's multiples at each month end with a market cap on file, Jan 2020 to Oct 2026, each against its own median.

P/E

31.0×

Now above its median of 24.3×, in the top quarter of its range; range 16.8× to 31.1× over 30 months.

0×8×16×23×31×2020202120222023202420252026P/E 31×Median 24×

Price to sales

6.7×

Now above its median of 5.2×, in the top quarter of its range; range 4.0× to 6.7× over 30 months.

0×2×3×5×7×2020202120222023202420252026Price to sales 7×Median 5×

Price to book

8.0×

Now above its median of 6.4×, in the top quarter of its range; range 5.0× to 8.0× over 30 months.

0×2×4×6×8×2020202120222023202420252026Price to book 8×Median 6×

As of Oct 29, 2026

The statements it starts from

USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.

Figures from the annual statements
Fiscal yearRevenueNet incomeCash from operationsCapital spendingFree cash flowNet debtSource
FY2026——————Wikidata
FY2025to Dec 28, 2025$94.2 B$26.8 B$24.5 B$4.8 B$19.7 B$21.7 BSEC annual report (10-K, 20-F)
FY2024to Dec 29, 2024$88.8 B$14.1 B$24.3 B$4.4 B$19.8 B$8.3 BSEC annual report (10-K, 20-F)
FY2023to Dec 31, 2023$85.2 B$35.2 B$22.8 B$4.5 B$18.2 B$5.5 BSEC annual report (10-K, 20-F)
FY2022to Jan 1, 2023$80.0 B$17.9 B$21.2 B$4.0 B$17.2 B$15.5 BSEC annual report (10-K, 20-F)
FY2021to Jan 2, 2022$78.7 B$20.9 B$23.4 B$3.7 B$19.8 B$17.6 BSEC annual report (10-K, 20-F)